INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

79,733 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PC
Perkins Tandra CDirector
CMCCOMMERCIAL METALS Co
Grant or award
A$1,233
19 sh
Apr 15, 2026Apr 16, 2026
Page 1192 of 1994
← PrevNext →
traded Apr 15, 2026
+1d
SEC Form 4

Evidence

9
DJ
Darden Tony JChief Operating Officer
PTLOPortillo's Inc.
Tax withholding
F$12K
2,182 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
BW
Bonifant William W.GVP, Chief Supply Chain Ofc.
HRLHORMEL FOODS CORP /DE/
Grant or award
A—
12.0K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

9
CV
Chen Wen-Chang (Victor)Chief Strategy Officer
ASAmer Sports, Inc.
Option exercise
M—
6,089 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$21K
10.2K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
SJ
Scaringe Robert JDirector, Chief Executive Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$347K
21.4K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

9
BW
Bonifant William W.GVP, Chief Supply Chain Ofc.
HRLHORMEL FOODS CORP /DE/
Grant or award
A—
87.7K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M—
9,215 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,250 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M—
10.7K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

6
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Grant or award
A—
109.8K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$67K
5,604 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$141K
12.0K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$14K
393 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
1,322 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$26K
12.7K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$32K
15.5K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
PK
Pilkington KyleCHIEF LEGAL OFFICER
SESSES AI Corp
Tax withholding
F$28K
25.2K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
GH
Gan HongCHIEF SCIENCE OFFICER
SESSES AI Corp
Tax withholding
F$35K
32.1K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
MM
Murphy Scott MChief Accounting Officer
RPDRapid7, Inc.
Tax withholding
F$1,981
344 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
PJ
Peil A JosephExecutive VP and CIO
EPRTESSENTIAL PROPERTIES REALTY TRUST, INC.
Grant or award
A—
165 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
HK
Hettrich KevinCHIEF FINANCIAL OFFICER
QSQuantumScape Corp
Grant or award
A—
86.1K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

4
HA
Haas Rene A.Director, Chief Executive Officer
ARMARM HOLDINGS PLC /UK
Open-market sale · 10b5-1 plan
SELL$907K
5,646 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

4
HA
Haas Rene A.Director, Chief Executive Officer
ARMARM HOLDINGS PLC /UK
Open-market sale · 10b5-1 plan
SELL$561K
3,483 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

3
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$19K
1,596 sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence

3
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M—
5,616 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

2
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$133K
6,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M$124K
11.0K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$56K
6,250 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$56K
2,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M$92K
9,215 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M$126K
10.7K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

1
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9,840
116 sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence

1
CD
Cassens Michael DavidDirector
BUSEFIRST BUSEY CORP /NV/
Open-market sale · 10b5-1 plan
SELL$20K
750 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

1
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

1
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence

0
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M$4,830
5,616 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
555.6K sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence